Literature DB >> 9688055

The effect of cross-linking on the in vivo disintegration of hard gelatin capsules.

J Brown1, N Madit, E T Cole, I R Wilding, D Cadé.   

Abstract

PURPOSE: To evaluate if the cross-linking of gelatin affects in vivo capsule disintegration.
METHODS: Scintigraphic investigation in nine healthy volunteers to provide for a real time visualisation of capsule disintegration.
RESULTS: The moderately stressed capsules failed the USP dissolution specification for acetaminophen capsule when tested in water and conventional SGF but passed with the addition of pepsin. Moderately stressed capsules started to disintegrate at 10 +/- 6 minutes (range 6 to 24 minutes) compared to 8 +/- 2 minutes (range 5 to 11 minutes) for the unstressed capsule.
CONCLUSIONS: The results of the study clearly demonstrate that with the incisive technique of gamma scintigraphy there are no differences in the in vivo disintegration properties of moderately stressed and unstressed capsules.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688055     DOI: 10.1023/a:1011973909815

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  What happens to tablets and capsules in the stomach: endoscopic comparison of disintegration and dispersion characteristics of two microencapsulated potassium formulations.

Authors:  D Y Graham; J L Smith; A A Bouvet
Journal:  J Pharm Sci       Date:  1990-05       Impact factor: 3.534

2.  The use of pharmacoscintigraphy to elucidate food effects observed with a novel protease inhibitor (saquinavir).

Authors:  C J Kenyon; F Brown; G R McClelland; I R Wilding
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

3.  The effect of in-vivo dispersion and gastric emptying on glibenclamide absorption from a novel, rapidly dissolving capsule formulation.

Authors:  J A Ganley; J McEwen; R T Calvert; M C Barker
Journal:  J Pharm Pharmacol       Date:  1984-11       Impact factor: 3.765

4.  The dissolution and bioavailability of etodolac from capsules exposed to conditions of high relative humidity and temperatures.

Authors:  M Dey; R Enever; M Kraml; D G Prue; D Smith; R Weierstall
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

Review 5.  Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance.

Authors:  G A Digenis; T B Gold; V P Shah
Journal:  J Pharm Sci       Date:  1994-07       Impact factor: 3.534

  5 in total
  6 in total

1.  Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture.

Authors:  G A Digenis; E P Sandefer; R C Page; W J Doll; T B Gold; N B Darwazeh
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

2.  The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules.

Authors:  M C Meyer; A B Straughn; R M Mhatre; A Hussain; V P Shah; C B Bottom; E T Cole; L L Lesko; H Mallinowski; R L Williams
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

3.  In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.

Authors:  Ewart T Cole; Robert A Scott; Dominique Cade; Alyson L Connor; Ian R Wilding
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

4.  Feasibility of capsule endoscopy for direct imaging of drug delivery systems in the fasted upper-gastrointestinal tract.

Authors:  Pernille Barbre Pedersen; Daniel Bar-Shalom; Stefania Baldursdottir; Peter Vilmann; Anette Müllertz
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

5.  Liqui-Tablet: the Innovative Oral Dosage Form Using the Newly Developed Liqui-Mass Technology.

Authors:  Matthew Lam; Kofi Asare-Addo; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2021-03-01       Impact factor: 3.246

6.  Comparison of In Vitro and In Vivo Results Using the GastroDuo and the Salivary Tracer Technique: Immediate Release Dosage Forms under Fasting Conditions.

Authors:  Maximilian Sager; Philipp Schick; Magdalena Mischek; Christian Schulze; Mahmoud Hasan; Marie-Luise Kromrey; Hassan Benameur; Martin Wendler; Mladen Vassilev Tzvetkov; Werner Weitschies; Mirko Koziolek
Journal:  Pharmaceutics       Date:  2019-12-07       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.